Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Second-Generation Corticosteroids for the Treatment of Crohns Disease and Ulcerative Colitis: More Effective and Less Side Effects
Frequency depends on a professional assessment
Chen K, Zhou A, Zhou X, He J, Xu Y, Ning X
Recent studies have shown that the lncRNA 00312/miR-34a-5p/ASS1 axis reduces proliferation and invasion and promotes apoptosis in RCC (113), and that the SNHG12/SP1/CDCA3 ferroptosis-related long non-coding RNA (FRIncRNA) axis promotes RCC progression and sunitinib resistance, thereby serving as a new target for the treatment of sunitinib-resistant RCC (114)
Cost and access : Both medications are expensive, and sermorelin for metabolic purposes is rarely covered by insurance, creating significant financial burden without guaranteed benefit
US$ 23.25
US$ 27.86
US$ 23.03
US$ 26.72
